AMISTAD

(redirected from Acute Myocardial Infarction Study of Adenosine)
Also found in: Wikipedia.

AMISTAD

Acute Myocardial Infarction Study of Adenosine. A clinical trial to determine the efficacy of IV adenosine with either streptokinase or tPA in limiting the size of acute MIs. 

Conclusion
33% decrease in infarct size seen with adenosine and 67% if the infarction was anterior in location; clinical outcomes with adenosine were slightly worse than with placebo.

AMISTAD

Cardiology A clinical trial–Acute Myocardial Infarction Study of Adenosine to determine the efficacy of IV adenosine in combination with either streptokinase or tPA in limiting the size of AMIs See Acute myocardial infarction.
Mentioned in ?
References in periodicals archive ?
NYSE:MRE) announced today that it has initiated its second multicenter Acute Myocardial Infarction STudy of ADenosine (AMISTAD-II) -- a Phase III study to further investigate the safety and efficacy of adenosine in combination with thrombolysis or angioplasty in the treatment of acute myocardial infarction (MI) or heart attack.

Full browser ?